Literature DB >> 6553485

Detection of kallikrein-like activity in inflamed synovial tissue.

J N Sharma, I J Zeitlin, S D Deodhar, W W Buchanan.   

Abstract

The synovial tissue kallikrein of rheumatoid patients, arthritic dogs and normal dogs has been partially characterized and estimated. Both human and dog synovial tissue kinin-forming enzyme appears to be distinct from plasmin, plasma kallikrein and pancreatic kallikrein. In three rheumatoid arthritic patients, the mean synovial tissue kallikrein level was found to be 106 +/- 13.5 ng bradykinin equivalents (BK Equiv) per g per min. In nine arthritic dogs the mean synovial tissue kallikrein level, 60.5 +/- 4.5 ng BK Equiv per g per min, was found to be greater (p less than 0.05) than that of five normal dogs (21.6 +/- 5.3 ng BK Equiv per g per min). The possible significance of this finding is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6553485

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  5 in total

1.  Pro-inflammatory properties of the kallikrein-kinin system: potential for new drug therapy.

Authors:  J N Sharma; A P Yusof
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

2.  Augmented plasma and tissue kallikrein like activity in synovial fluid of patients with inflammatory articular diseases.

Authors:  N Volpe-Júnior; E A Donadi; I F Carvalho; M L Reis
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

3.  Kinin-forming system in the genesis of hypertension.

Authors:  J N Sharma
Journal:  Agents Actions       Date:  1984-02

4.  Modifications in tissue kallikrein activity with indomethacin and prednisolone treatment in arthritic rats.

Authors:  J N Sharma
Journal:  Inflammopharmacology       Date:  2010-02-27       Impact factor: 4.473

5.  Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides.

Authors:  J M Bathon; D Proud; S Mizutani; P E Ward
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.